Tamoxifen inducible Cre (CreERT2-GFP) Adenovirus (Ad-GFP-CreERT2)

Produktübersicht

• Artikelname: Tamoxifen inducible Cre (CreERT2-GFP) Adenovirus (Ad-GFP-CreERT2)
• Artikelnummer: VBL-1795
• Hersteller Artikelnummer: 1795
• Alternativnummer: VBL-1795
• Hersteller: Vector Biolabs
• Kategorie: Sonstiges
• Alternative Synonym: Tamoxifen inducible Cre (CreERT2-GFP) Adenovirus

Produktbeschreibung

A mutated form of estrogen ligand-binding domain (ERT2) that binds to synthetic antagonists (such as tamoxifen or its derivative 4-hydroxy-tamoxifen) but not to circulating estrogens was fused to the Cre recombinase (Cre) to create the CreERT2, which requires the presence of tamoxifen for Cre recombinase activity. Therefore it makes possible to induce the recombination in cells with tamoxifen.This adenovirus expresses both CreERT2 and eGFP under the same CMV promoter, and the 2 genes are separated by a 2A polypeptide.

Produkteigenschaften

• Konzentration: 1x10 10 PFU/ml
• Puffer: DMEM, 2% BSA, 2.5% Glycerol

Bilder